laitimes

【Summary of important announcements of listed companies on the evening of January 28, 2022】I. Major Matters 1. Enhua Pharmaceutical [002262]: The subsidiary obtained nucleic acid testing for the new coronavirus

author:Financial Times

【Summary of Important Announcements of Listed Companies on the Evening of January 28, 2022】

1. Major matters

1. Enhua Pharmaceutical [002262]: The subsidiary obtained the qualification of nucleic acid testing service for the new coronavirus

2. Shanghai Pharmaceutical [601607]: Hydroxychloroquine sulfate tablets passed the consistency evaluation of generic drugs

3. Absolute Taste Food [603517]: The shareholding company and Fulao Noodles intend to implement the overseas listing plan

4. Lubei Chemical [600727]: Some production equipment will be stopped for maintenance from January 30

5. Haili Bio [603718]: The company's Shanghai factory has stopped production and relocated since January 28

6. Sinopharm Hyundai [600420]: Ceftriaxone sodium for injection has obtained overseas marketing authorization

7. Fucheng Shares [600965]: One of the actual controllers of the company received the judgment

8. Jinzi Ham [002515]: Receiving a letter of concern requires an explanation of whether there are major defects in the company's internal control

9. INVT [002334]: The listing application of the participating company BYD Semiconductor ON the ChiNext board was approved

Second, the performance of the express

1. Changhong Huayi [000404]: Net profit in 2021 pre-increase of 37.89%-72.36%

2, Jin An Guoji [002636]: 2021 net profit pre-increase 300% -350% year-on-year

3. Oriental Wealth [300059]: Net profit in 2021 pre-increased by 71.62%-86.27% year-on-year

4. Hao Haisheng [688366]: Net profit in 2021 pre-increased by 52.13% to 65.17% year-on-year

5. ZTE [000063]: Net profit in 2021 pre-increased by 52.59%-69.02% year-on-year

6. No. 9 Company[]: Net profit in 2021 pre-increased by 403.59% to 553.3% year-on-year

7. Yimikang [300249]: In 2021, it is expected to achieve a net profit of 25 million yuan - 35 million yuan year-on-year

8. Shengtun Mining [600711]: Net profit in 2021 pre-increased by 1762% to 2269% year-on-year

9. Sinoma Technology [002080]: Net profit in 2021 pre-increased by 60%-90% year-on-year

10. Zhongding Shares [000887]: Net profit in 2021 pre-increase of 90.84%-117.23%

11. Juguang Technology [688167]: Net profit in 2021 pre-increased by 77.8% to 106.48% year-on-year

12. Binhua Shares [601678]: Net profit in 2021 pre-increased by 220.52% year-on-year

13. Jiangsu Xinneng [603693]: Net profit in 2021 pre-increased by 101% year-on-year

14. Zijin Bank [601860]: Net profit in 2021 was 1.516 billion yuan, an increase of 5.2% year-on-year

15. China Gold [600916]: Net profit in 2021 pre-increased by about 60.08% year-on-year

16. NORD shares [600110]: Net profit in 2021 pre-increased by 7142% to 7699% year-on-year

17. Baosteel [600019]: Net profit in 2021 pre-increased by 86% to 89% year-on-year

18. CSG A [000012]: Net profit in 2021 pre-increase of 66%-109%

19. Penghui Energy [300438]: Net profit in 2021 pre-increased by 313.51%-388.69% year-on-year

20. Satellite Chemistry [002648]: Net profit in 2021 pre-increased by 243.17%-279.29% year-on-year

21. Shangchai Shares [600841]: Net profit in 2021 pre-increased by 83.44% to 94.31% year-on-year

22. Rongjie Shares [002192]: Net profit in 2021 pre-increased by 175.6%-256.38% year-on-year

23. Jiuqiang Biology [300406]: Net profit in 2021 pre-increased by 230%-300% year-on-year

24. Zhefu Holdings [002266]: Net profit in 2021 pre-increased by 61.53%-79.89% year-on-year

25, Mike Bio [300463]: 2021 net profit pre-increase of 15% -25% year-on-year

26. Junshi Bio [688180]: The net profit pre-loss in 2021 was 736 million yuan year-on-year

27. CanSino [688185]: 2021 pre-profit of 1.85 billion yuan to 2 billion yuan year-on-year turnaround

28. Air China [601111]: 14.5 billion yuan in 2021

29. Dongxin [688110]: Net profit in 2021 pre-increased by 1154.28% to 1307.87% year-on-year

3. Major investments

1. Wuliangye [000858]: The total investment of the proposed project to expand and transform the koji-making workshop is estimated at 2.75 billion yuan

2. Shuangliang Energy Saving [600481]: It is planned to invest 6.2 billion yuan in the second phase of the 20GW monocrystalline wafer project

3. Overclocking three [300647]: It is planned to invest 5 billion yuan to build a production base for key materials for lithium batteries cathode

4. Shanghai Silicon Industry [688126]: The subsidiary intends to invest 3.457 billion yuan in the construction of integrated circuit silicon material engineering research and development supporting projects

5. Sunflower [300111]: The subsidiary plans to invest 700 million yuan in the construction of pharmaceutical preparations and APIs projects

4. Refinancing

1. Mike Bio [300463]: As a result, Gao Yi's assets were allocated nearly 270 million yuan

2. Zhongxin Group [601512]: Intends to issue corporate bonds of not more than 2 billion yuan

3. Risen Energy [300118]: It is planned to raise no more than 5 billion yuan for projects such as ultra-low-carbon and high-efficiency heterojunction cells

4. Great Lakes Shares [600257]: It is planned to raise no more than 530 million yuan for the processing project of chilled frozen and cooked food products

5. Signing of contracts

1. Shangfeng Cement [000672]: The subsidiary intends to sign an investment cooperation agreement

2. Watson Biologics [300142]: Signed a cooperation agreement on the development and commercialization of mRNA vaccine technology for the novel coronavirus variant

6. Repurchase of shares

1. Xinlitai [002294]: It is proposed to increase the amount of repurchased shares

2. Huakai Creative [300592]: It is planned to repurchase shares for 50 million yuan to 100 million yuan

7. Increase holdings and decrease holdings

1. Phoenix-shaped shares [002760]: Shareholders intend to reduce their holdings by not more than 6.02%.

2. State Inspection Group [603060]: The company's 6 directors and supervisors are close to each other

【Summary of important announcements of listed companies on the evening of January 28, 2022】I. Major Matters 1. Enhua Pharmaceutical [002262]: The subsidiary obtained nucleic acid testing for the new coronavirus